Versigent (NYSE:VGNT) Releases Earnings Results, Beats Expectations By $0.12 EPS

Versigent (NYSE:VGNT – Get Free Report) released its earnings results on Wednesday. The company reported $1.91 earnings per share for the quarter, topping analysts’ consensus estimates of $1.79 by $0.12, Zacks reports.

Here are the key takeaways from Versigent’s conference call:

  • Versigent reported 7% sales growth, 11% higher adjusted EBITDA, and 40 basis points of margin expansion; adjusted sales grew about 1% despite global automotive production declining approximately 2%. This marked its sixth consecutive quarter of growth over market.
  • The company raised its 2026 free-cash-flow guidance to $275 million–$325 million, citing stronger year-to-date performance and the timing of some initiatives. The higher sales outlook reflects increased copper pass-throughs, while the adjusted EBITDA midpoint remains unchanged at $990 million.
  • Versigent reported more than 115 program launches so far this year, with over 99% quality and on-time delivery, and secured $7.5 billion in year-to-date bookings. Management said the launches and awards demonstrate its ability to execute complex programs and support future growth.
  • EMEA adjusted sales fell 8% amid weak demand, lower vehicle production, and program roll-offs. Elevated fourth-quarter launch activity and the lag in copper-cost recovery may also pressure sequential margins; management cautioned that third-quarter margins are not a new run rate.
  • Adjacent markets such as battery energy storage, power generation, and robotics are generating early wins, but many programs remain in development or small-scale production. Management said these opportunities are not expected to contribute meaningfully to its current outlook.

Versigent Stock Performance

Shares of VGNT traded up $1.73 during mid-day trading on Wednesday, hitting $42.42. 812,445 shares of the company traded hands, compared to its average volume of 1,520,966. The stock has a market cap of $3.00 billion and a price-to-earnings ratio of 22.32. The stock has a 50-day moving average price of $45.18 and a two-hundred day moving average price of $42.71. Versigent has a 1 year low of $26.34 and a 1 year high of $50.88. The company has a debt-to-equity ratio of 7.29, a quick ratio of 1.09 and a current ratio of 1.40.

Wall Street Analyst Weigh In

VGNT has been the topic of a number of analyst reports. The Goldman Sachs Group dropped their price target on Versigent from $59.00 to $58.00 and set a “buy” rating on the stock in a research report on Tuesday, October 6th. Oppenheimer set a $50.00 price target on shares of Versigent in a research note on Tuesday, July 21st. Royal Bank Of Canada upped their price target on shares of Versigent from $52.00 to $53.00 and gave the stock an “outperform” rating in a research note on Monday, October 12th. TD Cowen increased their price objective on shares of Versigent from $49.00 to $58.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $54.00 price objective on shares of Versigent in a research note on Wednesday, August 5th. Eleven analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Versigent currently has a consensus rating of “Moderate Buy” and a consensus target price of $54.00.

Read Our Latest Stock Report on VGNT

Insider Transactions at Versigent

In other Versigent news, Director Kevin Clark sold 47,761 shares of Versigent stock in a transaction that occurred on Thursday, October 8th. The shares were sold at an average price of $44.36, for a total value of $2,118,677.96. Following the completion of the sale, the director owned 27,571 shares of the company’s stock, valued at approximately $1,223,049.56. The trade was a 63.40% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders have sold a total of 220,000 shares of company stock valued at $10,065,848 in the last 90 days.

About Versigent

(Get Free Report)

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.

Read More

Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.